Menu
Log in


Member Login


  • Home
  • GSHP Webinar-10/7 PREVENTing ASCVD: Exploring the 2026 ACA/AHA Multisociety Dyslipidemia Guidelines

GSHP Webinar-10/7 PREVENTing ASCVD: Exploring the 2026 ACA/AHA Multisociety Dyslipidemia Guidelines

07 Oct 2026 12:00 PM | Steve Glass (Administrator)

FREE LIVE CE for GSHP Members! 

Wednesday, October 7, 2026 – 12:00pm-1:00 pm

PREVENTing ASCVD: Exploring the 2026 ACA/AHA Multisociety Dyslipidemia Guidelines

Presenter:

Zil Tyler, PharmD 

Clinical Pharmacist 

Medication Management Clinic 

Piedmont Athens Regional

Pharmacist Learning Objectives:

  • -          1. Apply the 2026 ACC/AHA Multi-society guideline recommendations to evaluate ASCVD risk in patients with dyslipidemia.
    2. Calculate and interpret ASCVD risk using the PREVENT-ASCVD risk equations.
    3. Develop lipid-lowering regimens based on updated treatment thresholds and goals.
    4. Optimize lipid-lowering therapy based on individualized ASCVD risk, updated treatment parameters and patient-specific considerations.
    5. Evaluate the role of non-statin therapies such as ezetimibe, PCSK9 inhibitors, and bempedoic acid in dyslipidemia management.

Pharmacy Technician Learning Objectives:

  • ·         Describe the purpose of ASCVD risk assessment in patients with dyslipidemia.
  • ·         Identify patient information used in the PREVENT-ASCVD risk equations.
  • ·         Recognize commonly used lipid-lowering medications, including statins, ezetimibe, PCSK9 inhibitors, and bempedoic acid.
  • ·         Identify common medication-related barriers, including cost, access, adherence, and adverse-effect concerns, that may affect lipid-lowering therapy.
  • ·         Describe the pharmacy technician’s role in medication reconciliation, adherence support, prior authorization assistance, and referral of clinical concerns to the pharmacist.

This is an application based activity.  This activity was planned to meet the educational needs of pharmacists and pharmacy technicians who practice in any setting.

Georgia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.   Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate completely in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit.

0228-0000-26-090-L01-P

0228-0000-26-090-L01-T

This is a member service of GSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20 for CE processing

To register (new process):  https://gshp.wildapricot.org/event-6856878

Note: In the confirmation email, you will receive the zoom link to participate in the webinar.



Address: 3015 Shannon Lakes North | Suite 303 | Tallahassee, FL 32309

Phone: 850-728-4474


GSHP is a state affiliate of the American Society of Health-System Pharmacists

Copyright © 2026 Georgia Society of Health-System Pharmacists. All rights reserved.

Powered by Wild Apricot Membership Software